Effector and memory CTL differentiation

Annual Review of Immunology

Volumn 25, Issue , 2007, Pages 171-192

  Williams, Matthew A ^a   Bevan, Michael J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cytotoxic T lymphocytes; Immunologic memory; T lymphocyte differentiation

Indexed keywords

AMPICILLIN; CD4 ANTIGEN; CD8 ANTIGEN; INTERFERON; INTERLEUKIN 12;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; BACTERIAL INFECTION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOSTIMULATION; LISTERIOSIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; BACTERIAL VACCINES; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES, CYTOTOXIC; VIRAL VACCINES; VIRUS DISEASES;

EID: 34247849183     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.25.022106.141548     Document Type: Review

References (156)

1. Blattman JN, Antia R, Sourdive DJD, Wang X, Kaech SM, et al. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:657-64
2. + T cells during an acute virus infection. Immunity 8:167-75
3. + T cells. Science 280:227
4. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, et al. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-87
5. Kaech SM, Wherry EJ, Ahmed R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-62
6. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, et al. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9:1131-37
7. Lanzavecchia A, Sallusto F. 2002. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2:982-87
8. Masopust D, Kaech SM, Wherry EJ, Ahmed R. 2004. The role of programming in memory T-cell development. Curr. Opin. Immunol. 16:217-25
9. Williams MA, Bevan MJ. 2004. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J. Immunol. 173:6694-702
10. + T cell response. J. Exp. Med. 201:1555-65
11. van Stipdonk MJ, Lemmens EE, Schoenberger SP. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423-29
12. + T lymphocyte responses. Nat. Immunol. 4:361-65
13. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4:355-60
14. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415-22
15. Mercado R, Vijh S, Allen SE, Kerksiek K, Pilip IM, Pamer EG. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165:6833-39
16. Wong P, Pamer EG. 2003. Feedback regulation of pathogen-specific T cell priming. Immunity 18:499-511
17. + T cells by exogenous cell-associated antigens. Immunity 17:211-20
18. + T cell response. J. Exp. Med. 203:2135-43
19. + T cells after infection. Nat. Immunol. 3:619-26
20. Probst HC, den van Broek M. 2005. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J. Immunol. 174:3920-24
21. Zammit DJ, Cauley LS, Pham QM, Lefrancois L. 2005. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22:561-70
22. Lenz LL, Butz EA, Bevan MJ. 2000. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 192:1135-42
23. + T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198:399-410
24. Mempel TR, Henrickson SE, Von Andrian UH. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154-59
25. + T-cell response. Nat. Rev. Immunol. 4:595-602
26. + T cells: when, where, and how. Annu. Rev. Immunol. 24:519-40
27. + T cell help. J. Exp. Med. 186:65-70
28. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478-80
29. + T-helper and a T-killer cell. Nature 393:474-78
30. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-83
31. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353:180-84
32. Buller RM, Holmes KL, Hugin A, Frederickson TN, Morse HC. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77-79
33. + T-cell responses. Curr. Biol. 4:499-505
34. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102-6
35. Janeway CAJ, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216
36. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-95
37. Reis e Sousa C. 2001. Dendritic cells as sensors of infection. Immunity 14:495-98
38. Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, et al. 2002. Interferon-α and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195:1507-12
39. Palliser D, Ploegh H, Boes M. 2004. Myeloid differentiation factor 88 is required for cross-priming in vivo. J. Immunol. 172:3415-21
40. + T lymphocytes. Nature 421:852-56
41. Shedlock DJ, Shen H. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337-39
42. Sun JC, Bevan MJ. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339-42
43. + T cell memory. Science 297:2060-63
44. + T cells generated depends on the nature of the initial nonspecific stimulation. Eur. J. Immunol. 32:1541-49
45. + T cell responses in vivo. J. Immunol. 171:6339-43
46. + T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4:1009-15
47. Sun JC, Bevan MJ. 2004. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J. Immunol. 172:3385-89
48. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-63
49. Whitmire JK, Flavell RA, Grewal IS, Larsen CP, Pearson TC, Ahmed R. 1999. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J. Immunol. 163:3194-201
50. + T cells. J. Exp. Med. 184:863-71
51. + T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12:375-80
52. D'Souza WN, Lefrancois L. 2003. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171:5727-35
53. D'Souza WN, Schluns KS, Masopust D, Lefrancois L. 2002. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J. Immunol. 168:5566-72
54. + memory T cells. Nature 441:890-93
55. Yu A, Zhou J, Marten N, Bergmann CC, Mammolenti M, et al. 2003. Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors. J. Immunol. 170:236-42
56. Schwartz RH. 2003. T cell anergy. Annu. Rev. Immunol. 21:305-34
57. Carreno BM, Collins M. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29-53
58. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-38
59. Larsen CP, Knechtle SJ, Adams A, Pearson T, Kirk AD. 2006. A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression. Am. J. Transplant. 6:876-83
60. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, et al. 1999. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103:1243-52
61. Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, et al. 2003. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349:1907-15
62. Lenschow DJ, Walunas TL, Bluestone JA. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-58
63. Sharpe AH, Freeman GJ. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-26
64. Shedlock DJ, Whitmire JK, Tan J, MacDonald AS, Ahmed R, Shen H. 2003. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 170:2053-63
65. + effector T cell responses. J. Immunol. 164:3689-97
66. Liu Y, Wenger RH, Zhao M, Nielsen PJ. 1997. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185:251-62
67. Kundig TM, Shahinian A, Kawai K, Mittrucker HW, Sebzda E, et al. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41-52
68. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, et al. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609-12
69. Zimmermann C, Seiler P, Lane P, Zinkernagel RM. 1997. Antiviral immune responses in CTLA4 transgenic mice. J. Virol. 71:1802-7
70. Tan JT, Whitmire JK, Ahmed R, Pearson TC, Larsen CP. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163:4859-68
71. Kwon BS, Hurtado JC, Lee ZH, Kwack KB, Seo SK, et al. 2002. Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 168:5483-90
72. DeBenedette MA, Wen T, Bachmann MF, Ohashi PS, Barber BH, et al. 1999. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163:4833-41
73. + T cells. Am. J. Transplant. 3:543-51
74. Tan JT, Whitmire JK, Murali-Krishna K, Ahmed R, Altman JD, et al. 2000. 4-1BB costimulation is required for protective antiviral immunity after peptide vaccination. J. Immunol. 164:2320-5
75. Bertram EM, Dawicki W, Sedgmen B, Bramson JL, Lynch DH, Watts TH. 2004. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J. Immunol. 172:981-88
76. Dawicki W, Bertram EM, Sharpe AH, Watts TH. 2004. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. J. Immunol. 173:5944-51
77. Bertram EM, Lau P, Watts TH. 2002. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol. 168:3777-85
78. Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H, et al. 2001. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167:1313-24
79. Gramaglia I, Cooper D, Miner KT, Kwon BS, Croft M. 2000. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur. J. Immunol. 30:392-402
80. + T cell responses. Nat. Immunol. 3:536-41
81. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-40
82. Hendriks J, Xiao Y, Borst J. 2003. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198:1369-80
83. Matter M, Mumprecht S, Pinschewer DD, Pavelic V, Yagita H, et al. 2005. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL. Eur. J. Immunol. 35:3229-39
84. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-46
85. + T cells. J. Immunol. 162:3256-62
86. + T cells in vivo. J. Immunol. 163:2561-67
87. Curtsinger JM, Lins DC, Mescher MF. 2003. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197:1141-51
88. Curtsinger JM, Lins DC, Johnson CM, Mescher MF. 2005. Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis. J. Immunol. 175:4392-99
89. Valenzuela JO, Hammerbeck CD, Mescher MF. 2005. Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells. J. Immunol. 174:600-4
90. Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, et al. 1999. Two roads diverged: interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189:1315-28
91. Marrack P, Kappler J, Mitchell T. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189:521-30
92. Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174:4465-69
93. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202:637-50
94. + T cell response during cross-priming. J. Immunol. 176:4682-89
95. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K. 2006. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 177:1746-54
96. Wherry EJ, Ahmed R. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78:5535-45
97. Fuller MJ, Khanolkar A, Tebo AE, Zajac AJ. 2004. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 172:4204-14
98. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-27
99. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJD, Suresh M, et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-13
100. Wherry EJ, Blattman JN, Ahmed R. 2005. Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J. Virol. 79:8960-68
101. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. 2004. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA 101:16004-9
102. Rickinson AB, Moss DJ. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-31
103. Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB. 2006. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J. Immunol. 177:450-58
104. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-87
105. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-54
106. + T cells leads to reversible immune dysfunction. Nat. Med. 12:1198-202
107. + T cell survival in HIV infection. J. Exp. Med. 203:2281-92
108. + memory T cell subsets. Proc. Natl. Acad. Sci. USA 101:5610-15
109. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-98
110. Sun JC, Lehar SM, Bevan MJ. 2006. Augmented IL-7 signaling during viral infection drives greater expansion of effector T cells but does not enhance memory. J. Immunol. 177:4458-63
111. Klonowski KD, Williams KJ, Marzo AL, Lefrancois L. 2006. Cutting edge: IL-7-independent regulation of IL-7 receptor alpha expression and memory CD8 T cell development. J. Immunol. 107:4247-51
112. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11:748-56
113. + memory T lymphocyte precursors following peptide immunization. J. Immunol. 175:4400-7
114. Zhang M, Park SM, Wang Y, Shah R, Liu N, et al. 2006. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity 24:451-61
115. Liu Y, Xiong Y, Naidenko OV, Liu JH, Zhang R, et al. 2003. The crystal structure of a TL/CD8αα complex at 2.1 Å resolution: implications for modulation of T cell activation and memory. Immunity 18:205-15
116. Madakamutil LT, Christen U, Lena CJ, Wang-Zhu Y, Attinger A, et al. 2004. CD8αα-mediated survival and differentiation of CD8 memory T cell precursors. Science 304:590-93
117. Williams MA, Bevan MJ. 2005. Cutting edge: a single MHC class Ia is sufficient for CD8 memory T cell differentiation. J. Immunol. 175:2066-69
118. Chandele A, Kaech SM. 2005. Cutting edge: memory CD8 T cell maturation occurs independently of CD8αα. J. Immunol. 175:5619-23
119. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6:1236-44
120. Juedes AE, Rodrigo E, Togher L, Glimcher LH, von Herrath MG. 2004. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J. Exp. Med. 199:1153-62
121. Pellegrini M, Belz G, Bouillet P, Strasser A. 2003. Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc. Natl. Acad. Sci. USA 100:14175-80
122. Wojciechowski S, Jordan MB, Zhu Y, White J, Zajac AJ, Hildeman DA. 2006. Bim mediates apoptosis of CD127(lo) effector T cells and limits T cell memory. Eur. J. Immunol. 36:1694-706
123. Kaech SM, Hemby S, Kersh E, Ahmed R. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837-51
124. Wong P, Lara-Tejero M, Ploss A, Leiner I, Pamer EG. 2004. Rapid development of T cell memory. J. Immunol. 172:7239-45
125. + T cells after acute infection. Nat. Immunol. 5:927-33
126. Northrop JK, Thomas RM, Wells AD, Shen H. 2006. Epigenetic remodeling of the IL-2 and IFN-γ loci in memory CD8 T cells is influenced by CD4 T cells. J. Immunol. 177:1062-69
127. + T cell-dendritic cell interaction. Nature 440:890-95
128. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434:88-93
129. + T cells. Nat. Immunol. 7:475-81
130. Badovinac VP, Nordyke Messingham KA, Griffith TS, Harty JT. 2006. TRAIL deficiency delays, but does not prevent, erosion in the quality of helpless memory CD8 T cells. J. Immunol. 177:999-1006
131. Khanolkar A, Fuller MJ, Zajac AJ. 2004. CD4 T cell-dependent CD8 T cell maturation. J. Immunol. 172:2834-44
132. Rickert M, Wang X, Boulanger MJ, Goriatcheva N, Garcia KC. 2005. The structure of interleukin-2 complexed with its alpha receptor. Science 308:1477-80
133. Stauber DJ, Debler EW, Horton PA, Smith KA, Wilson IA. 2006. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc. Natl. Acad. Sci. USA 103:2788-93
134. Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-63
135. Unsoeld H, Pircher H. 2005. Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7. J. Virol. 79:4510-13
136. + T cell lineage commitment. Nat. Immunol. 6:793-99
137. Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, Lefrancois L. 2004. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 20:551-62
138. + T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J. Immunol. 172:857-63
139. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, et al. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424:88-93
140. Dudda JC, Lembo A, Bachtanian E, Huehn J, Siewert C, et al. 2005. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. Eur. J. Immunol. 35:1056-65
141. Mora JR, Cheng G, Picarella D, Briskin M, Buchanan N, von Andrian UH. 2005. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J. Exp. Med. 201:303-16
142. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21:527-38
143. + T cells. Proc. Natl. Acad. Sci. USA 98:6313-18
144. Masopust D, Vezys V, Usherwood EJ, Cauley LS, Olson S, et al. 2004. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J. Immunol. 172:4875-82
145. Klonowski KD, Lefrancois L. 2005. The CD8 memory T cell subsystem: integration of homeostatic signaling during migration. Semin. Immunol. 17:219-29
146. Ma A, Koka R, Burkett P. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24:657-79
147. Surh CD, Sprent J. 2005. Regulation of mature T cell homeostasis. Semin. Immunol. 17:183-91
148. Mortier E, Bernard J, Plet A, Jacques Y. 2004. Natural, proteolytic release of a soluble form of human IL-15 receptor α-chain that behaves as a specific, high affinity IL-15 antagonist. J. Immunol. 173:1681-88
149. Mortier E, Quemener A, Vusio P, Lorenzen I, Boublik Y, et al. 2006. Soluble interleukin-15 receptor α (IL-15Rα)-sushi as a selective and potent agonist of IL-15 action through IL-15R β/γ. Hyperagonist IL-15 x IL-15Rα fusion proteins. J. Biol. Chem. 281:1612-19
150. Rubinstein MP, Kovar M, Purton JF, Cho JH, Boyman O, et al. 2006. Converting IL-15 to a superagonist by binding to soluble IL-15Rα. Proc. Natl. Acad. Sci. USA 103:9166-71
151. Pulle G, Vidric M, Watts TH. 2006. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J. Immunol. 176:2739-48
152. + memory T cells and their capacity for secondary expansion. J. Immunol. 175:1665-76
153. Jabbari A, Harty JT. 2005. Cutting edge: differential self-peptide/MHC requirement for maintaining CD8 T cell function versus homeostatic proliferation. J. Immunol. 175:4829-33
154. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286:1377-81
155. Polic B, Kunkel D, Scheffold A, Rajewsky K. 2001. How αβ T cells deal with induced TCRα ablation. Proc. Natl. Acad. Sci. USA 98:8744-49
156. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201:723-35